An experimental study of bisphosphonate-induced jaws osteonecrosis in Sprague-Dawley rats

Journal of Oral Pathology and Medicine

Volumn 39, Issue 9, 2010, Pages 697-702

  López Jornet, Pía ^a   Camacho Alonso, Fabio ^a   Molina Miñano, Francisco ^a   Gómez García, Francisco ^a   Vicente Ortega, Vicente ^a  

^a UNIVERSITY OF MURCIA   (Spain)

Author keywords

bisphosphonates; maxillary osteonecrosis; pamidronate

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; DEXAMETHASONE; PAMIDRONIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BISPHOSPHONATE RELATED OSTEONECROSIS OF THE JAW; BONE NECROSIS; CONTROLLED STUDY; DRUG INDUCED DISEASE; EXPERIMENTAL MODEL; HISTOLOGY; JAW OSTEONECROSIS; MALE; MAXILLA; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; SPRAGUE DAWLEY RAT; TOOTH EXTRACTION;

ANIMALS; BONE DENSITY CONSERVATION AGENTS; DEXAMETHASONE; DIPHOSPHONATES; DRUG COMBINATIONS; GLUCOCORTICOIDS; INFLAMMATION; JAW; JAW DISEASES; MALE; NEOVASCULARIZATION, PATHOLOGIC; OSTEONECROSIS; PROSPECTIVE STUDIES; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; TOOTH EXTRACTION;

EID: 77957554775     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2010.00927.x     Document Type: Article

References (27)

1. Aapro M, Abrahamsson PA, Body JJ, et al. Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel. Ann Oncol 2008 19 : 420 432.
2. McClung MR. Bisphosphonates. Endocrinol Metab Clin North Am 2003 32 : 3253 3271.
3. Lin JH. Bisphosphonates: a review of their pharmacokinetic properties. Bone 1996 18 : 75 85.
4. Santini D, Vespasiani-Gentilucci U, Vincenzi B, et al. The antineoplastic role of bisphosphonates: from basic research to clinical evidence. Ann Oncol 2003 14 : 1468 1476.
5. Riebeling C, Forsea AM, Raisova M, Orfanos CE, Geilen CC. The bisphosphonate pamidronate induces apoptosis in human melanoma cells in vitro. Br J Cancer 2002 87 : 366 371.
6. Wood J, Bonjean K, Ruetz S, et al. Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid. J Pharmacol Exp Ther 2002 302 : 1055 1061.
7. Santini D, Vincenzi B, Dicuonzo G, et al. Zoledronic acid induces significant and long-lasting modifications of circulating angiogenic factors in cancer patients. Clin Cancer Res 2003 9 : 2893 2897.
8. Boonyapakorn T, Schirmer I, Reichart PA, Sturm I, Massenkeil G. Bisphosphonate-induced osteonecrosis of the jaws: prospective study of 80 patients with multiple myeloma and other malignancies. Oral Oncol 2008 44 : 857 869.
9. Marx RE. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 2003 61 : 1115 1117.
10. Bagan JV, Scully C, Sabater V, Jimenez Y. Osteonecrosis of the jaws in patients treated with intravenous bisphosphonates (BRONJ): a concise update. Oral Oncol 2009 45 : 551 554.
11. Bagan JV, Murillo J, Jimenez Y, et al. Avascular jaw osteonecrosis in association with cancer chemotherapy: a series of 10 cases. J Oral Pathol Med 2005 34 : 120 123.
12. Migliorati CA. Bisphosphonates and oral cavity avascular bone necrosis. J Clin Oncol 2003 21 : 4253 4254.
13. Farrugia MC, Summerlin D-J, Krowiak E, et al. Osteonecrosis of the mandible or maxilla associated with the use of new generation bisphosphonates. Laryngoscope 2006 116 : 115 120.
14. Wutzl A, Biedermann E, Wanschitz F, et al. Treatment results of bisphosphonate-related osteonecrosis of the jaws. Head Neck 2008 30 : 1224 1230.
15. Bamias A, Kastritis E, Bamia C, et al. Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors. J Clin Oncol 2005 34 : 8580 8587.
16. Wang EP, Kaban LB, Strewler GJ, Raje N, Troulis MJ. Incidence of osteonecrosis of the jaw in patients with multiple myeloma and breast cancer on intravenous bisphosphonate therapy. J Oral Maxillofac Surg 2007 65 : 1328 1331.
17. Hoff A, Toth BB, Altundag K, et al. Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates. J Bone Miner Res 2008 23 : 826 836.
18. Abu-Id MH, Warnke PH, Gottschalk J, et al. "Bisphossy jaws"- high and low risk factors for bisphosphonate-induced osteonecrosis of the jaw. J Craniomaxillofac Surg 2008 36 : 95 103.
19. Ruggiero SL, Thomas B, Dodson TB, et al. American Association of Oral and Maxillofacial Surgeons Position Paper on Bisphosphonate-Related Osteonecrosis of the Jaws - 2009 Update. J Oral Maxillofac Surg 2009 67 : 2 12.
20. Ruggiero SL, Mehrotra B, Rosenberg TJ, Engroff SL. Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg 2004 62 : 527 534.
21. Allen MR, Burr DB. The pathogenesis of bisphosphonate-related osteonecrosis of the jaw: so many hypotheses, so few data. J Oral Maxillofac Surg 2009 67 : 61 70.
22. Sonis ST, Watkins BA, Lyng GD, Lerman MA, Anderson KC. Bony changes in the jaws of rats treated with zoledronic acid and dexamethasone before dental extractions mimic bisphosphonate-related osteonecrosis in cancer patients. Oral Oncol 2009 45 : 164 172.
23. Reid IR. Osteonecrosis of the jaw. Who gets it and why? Bone 2009 44 : 4 10.
24. Lugassy G, Shaham R, Nemets A, Ben-Dor D, Nahlieli O. Severe osteomyelitis of the jaw in long-term survivors of multiple myeloma: a new clinical entity. Am J Med 2004 117 : 440 441.
25. Melo MD, Obeid G. Osteonecrosis of the maxilla in a patient with a history of bisphosphonate therapy. J Can Dent Assoc 2005 71 : 11 13.
26. Hansen T, Kunkel M, Springer E, et al. Actinomycosis of the jaws - histopathological study of 45 patients shows significant involvement in bisphosphonate-associated osteonecrosis and infected osteoradionecrosis. Virchows Arch 2007 451 : 1009 1017.
27. Sedghizadeh PP, Kumar SK, Gorur A, Schaudinn C, Shuler CF, Costerton JW. Microbial biofilms in osteomyelitis of the jaw and osteonecrosis of the jaw secondary to bisphosphonate therapy. J Am Dent Assoc 2009 140 : 1259 1265.